{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T04:25:10Z","timestamp":1768969510046,"version":"3.49.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Eunice Kennedy Shriver NICHD at the National Institutes of Health","award":["HHSN275200403366"],"award-info":[{"award-number":["HHSN275200403366"]}]},{"name":"Eunice Kennedy Shriver NICHD at the National Institutes of Health","award":["HHSN275200403377"],"award-info":[{"award-number":["HHSN275200403377"]}]},{"name":"Eunice Kennedy Shriver NICHD at the National Institutes of Health","award":["HHSN275200403382"],"award-info":[{"award-number":["HHSN275200403382"]}]},{"DOI":"10.13039\/100005974","name":"Population Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005974","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.contraception.2015.09.008","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:58:50Z","timestamp":1443229130000},"page":"58-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone\u00ae and ethinyl estradiol"],"prefix":"10.1016","volume":"93","author":[{"given":"D.F.","family":"Archer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Conard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.B.","family":"Merkatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.W.","family":"Creasy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Plagianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Blithe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Sitruk-Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2015.09.008_bb0005","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2007.02450.x","article-title":"Incidence and mortality of venous thrombosis: a population-based study","volume":"5","author":"Naess","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2015.09.008_bb0010","doi-asserted-by":"crossref","first-page":"d6423","DOI":"10.1136\/bmj.d6423","article-title":"Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001\u20139","volume":"343","author":"Lidegaard","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2015.09.008_bb0015","doi-asserted-by":"crossref","first-page":"e4944","DOI":"10.1136\/bmj.e4944","article-title":"Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis","volume":"345","author":"Mantha","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2015.09.008_bb0020","first-page":"191","article-title":"Oral contraceptives and venous thromboembolism: a systematic review and meta-analysis","volume":"35","author":"Manzoli","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.contraception.2015.09.008_bb0025","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.beem.2012.11.003","article-title":"Hormonal contraceptives and arterial disease: an epidemiological update","volume":"27","author":"Plu-Bureau","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2015.09.008_bb0030","doi-asserted-by":"crossref","first-page":"f5298","DOI":"10.1136\/bmj.f5298","article-title":"Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis","volume":"347","author":"Stegeman","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2015.09.008_bb0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/AOG.0b013e3182994c43","article-title":"Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis","volume":"122","author":"Peragallo Urrutia","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.09.008_bb0040","author":"FDA"},{"key":"10.1016\/j.contraception.2015.09.008_bb0045","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/bmj.323.7305.131","article-title":"Third generation oral contraceptives and risk of venous thrombosis: meta-analysis","volume":"323","author":"Kemmeren","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2015.09.008_bb0050","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case\u2013control study","volume":"339","author":"van Hylckama","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2015.09.008_bb0055","doi-asserted-by":"crossref","first-page":"h2135","DOI":"10.1136\/bmj.h2135","article-title":"Use of combined oral contraceptives and risk of venous thromboembolism: nested case\u2013control studies using the QResearch and CPRD databases","volume":"350","author":"Vinogradova","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2015.09.008_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.contraception.2014.01.023","article-title":"Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives","volume":"89","author":"Dinger","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.09.008_bb0065","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0038-1657546","article-title":"Effect of oral contraceptives on haemostasis variables","volume":"78","author":"Kluft","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2015.09.008_bb0070","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0037-1613958","article-title":"Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study","volume":"84","author":"Middeldorp","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2015.09.008_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0037-1613960","article-title":"A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways","volume":"84","author":"Tans","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.contraception.2015.09.008_bb0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/humrep\/deh612","article-title":"Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens","volume":"20","author":"van Vliet","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2015.09.008_bb0085","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.contraception.2009.05.131","article-title":"Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis","volume":"81","author":"van Vliet","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.09.008_bb0090","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.contraception.2015.09.008_bb0095","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1538-7836.2004.00894.x","article-title":"Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives","volume":"2","author":"Alhenc-Gelas","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2015.09.008_bb0100","first-page":"482","article-title":"Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?","volume":"81","author":"Odlind","year":"2002","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.contraception.2015.09.008_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.AOG.0000250968.82370.04","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users","volume":"109","author":"Cole","year":"2007","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.09.008_bb0110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/jth.12080","article-title":"Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: reply to a rebuttal","volume":"11","author":"Raps","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2015.09.008_bb0115","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1111\/j.1538-7836.2012.04878.x","article-title":"Sex hormone-binding globulin levels are not causally related to venous thrombosis risk in women not using hormonal contraceptives","volume":"10","author":"Stegeman","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.contraception.2015.09.008_bb0120","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/01.AOG.0000157445.67309.19","article-title":"Surrogate end points in clinical research: hazardous to your health","volume":"105","author":"Grimes","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.09.008_bb0125","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1097\/AOG.0b013e3181f98300","article-title":"Epidemiologic research using administrative databases: garbage in, garbage out","volume":"116","author":"Grimes","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.09.008_bb0130","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.contraception.2014.02.002","article-title":"Oral hormonal contraception and venous thromboembolism (VTE)","volume":"89","author":"Reid","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.09.008_bb0135","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jclinepi.2009.03.018","article-title":"Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution","volume":"63","author":"Severinsen","year":"2010","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.contraception.2015.09.008_bb0140","doi-asserted-by":"crossref","first-page":"R221","DOI":"10.1530\/EJE-14-0527","article-title":"Epidemiology of hormonal contraceptives-related venous thromboembolism","volume":"171","author":"Hugon-Rodin","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.contraception.2015.09.008_bb0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.contraception.2006.01.001","article-title":"Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.09.008_bb0150","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.contraception.2009.12.009","article-title":"Extended case\u2013control study results on thromboembolic outcomes among transdermal contraceptive users","volume":"81","author":"Dore","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.09.008_bb0155","doi-asserted-by":"crossref","first-page":"e2990","DOI":"10.1136\/bmj.e2990","article-title":"Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001\u201310","volume":"344","author":"Lidegaard","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2015.09.008_bb0160","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajog.2005.12.007","article-title":"Comparative effects of a contraceptive vaginal ring delivering a nonandrogenic progestin and continuous ethinyl estradiol and a combined oral contraceptive containing levonorgestrel on hemostasis variables","volume":"195","author":"Rad","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.09.008_bb0165","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2007-0026","article-title":"Effects of oral and transvaginal ethinyl estradiol on hemostatic factors and hepatic proteins in a randomized, crossover study","volume":"92","author":"Sitruk-Ware","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.contraception.2015.09.008_bb0170","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1097\/AOG.0b013e3181626d1b","article-title":"Effects of oral and transdermal hormonal contraception on vascular risk markers: a randomized controlled trial","volume":"111","author":"Johnson","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.09.008_bb0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.contraception.2007.10.004","article-title":"Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables","volume":"77","author":"Kluft","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.09.008_bb0180","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0010-7824(02)00436-5","article-title":"Effect of four different oral contraceptives on various sex hormones and serum-binding globulins","volume":"67","author":"Wiegratz","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.09.008_bb0185","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.contraception.2008.06.015","article-title":"Effects of conventional or extended-cycle regimen of an oral contraceptive containing 30mcg ethinylestradiol and 2mg dienogest on various hemostasis parameters","volume":"78","author":"Wiegratz","year":"2008","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.09.008_bb0190","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.contraception.2009.12.005","article-title":"An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02mg ethinylestradiol\/2mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables","volume":"81","author":"Winkler","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.09.008_bb0195","series-title":"Medical Eligibility for Contraceptive Use","first-page":"121","author":"Organization W-WH","year":"2010"},{"key":"10.1016\/j.contraception.2015.09.008_bb0200","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ando.2012.09.001","article-title":"Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology","volume":"73","author":"Gourdy","year":"2012","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.contraception.2015.09.008_bb0205","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5482\/ha-1177","article-title":"Hormonal contraception in thrombophilic adolescents: risk of thrombosis and recommendations","volume":"32","author":"Rott","year":"2012","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.contraception.2015.09.008_bb0210","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9378(03)00950-5","article-title":"Sex hormone-binding globulin \u2014 a surrogate marker for the prothrombotic effects of combined oral contraceptives","volume":"190","author":"van Rooijen","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2015.09.008_bb0215","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2015.09.008_bb0220","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1111\/j.1538-7836.2010.03840.x","article-title":"A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin","volume":"8","author":"Mahmoodi","year":"2010","journal-title":"J Thromb Haemost"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415005831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782415005831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T00:27:32Z","timestamp":1567211252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782415005831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0010782415005831"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2015.09.008","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact on hepatic estrogen-sensitive proteins by a 1-year contraceptive vaginal ring delivering Nestorone\u00ae and ethinyl estradiol","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2015.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}